| In silico guided drug repurposing to combat SARS-CoV-2 by Targeting Mpro, the key virus specific protease A Singh, R Rani, A Pareek, S Tomar, P Kumar | 8 | 2023 |
| Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins R Rani, S Long, A Pareek, P Dhaka, A Singh, P Kumar, G McInerney, ... Virology 577, 1-15, 2022 | 7 | 2022 |
| Biochemical and biophysical insights into the metal binding spectrum and bioactivity of arginase of Entamoeba histolytica A Malik, H Singh, A Pareek, S Tomar Metallomics 10 (4), 623-638, 2018 | 7 | 2018 |
| RNA-Dependent RNA Polymerase of Alphaviruses: A Potential Target for the Design of Drugs Against Alphaviruses S Tomar, R Mudgal, A Pareek Viral polymerases, 69-94, 2019 | 6* | 2019 |
| Identification and evaluation of potential inhibitor molecules against TcyA from Candidatus Liberibacter asiaticus S Lonare, M Sharma, V Dalal, M Gubyad, P Kumar, DN Gupta, A Pareek, ... Journal of Structural Biology 215 (3), 107992, 2023 | 4 | 2023 |
| Alphavirus antivirals targeting RNA‐dependent RNA polymerase domain of nsP4 divulged using surface plasmon resonance A Pareek, R Kumar, R Mudgal, N Neetu, M Sharma, P Kumar, S Tomar The FEBS Journal 289 (16), 4901-4924, 2022 | 3 | 2022 |
| Targeting host protein G3BP1 for the discovery of novel antiviral inhibitors against the Chikungunya virus S Mahajan, R Kumar, A Singh, A Pareek, S Long, G McInerney, S Tomar bioRxiv, 2022.11. 11.516135, 2022 | | 2022 |
| In Silico Guided Drug A Singh, A Pareek, S Tomar | | 2020 |
